骨肉瘤

B7-H3 在肉瘤中的临床与治疗相关性：来自系统综述的分子见解

Clinical and Therapeutic Relevance of B7-H3 in Sarcomas: Molecular Insights from a Systematic Review.

肉瘤是一组异质性间叶源性恶性肿瘤，以显著的形态学和分子学多样性为特征。

弥合骨肉瘤 T 细胞疗法转化差距：临床前模型的叙述性批判性综述

Bridging the Translational Gap in Osteosarcoma T-Cell Therapy: A Narrative Critical Review of Preclinical Models.

TP53 缺失通过上调 NF-κB-IFN-β-MHC-Ia 信号促进骨肉瘤对 NK 细胞的抵抗

TP53 Loss Elevates NF-κB-IFN-β-MHC-Ia Signaling to Promote NK Cell Resistance in Osteosarcoma.

人类与犬骨肉瘤的整合转录组学揭示物种干性与曲贝替定敏感性

Integrated Transcriptomics of Human and Canine Osteosarcoma Reveals Species Stemness and Trabectedin Sensitivity.

甘草查尔酮 B 通过 Hedgehog 信号通路抑制 Neuritin 1 驱动的神经周围侵犯和骨肉瘤进展

Licochalcone B inhibits Neuritin 1-driven perineural invasion and osteosarcoma progression via the Hedgehog signaling pathway.

LCB 通过靶向 NRN1 在 OS 中发挥全面的抗肿瘤作用，同时抑制 Hedgehog 信号通路、减轻神经周围侵犯并恢复 NK 细胞介导的抗肿瘤免疫，这可能成为改善患者预后的一种有前景的治疗策略。

四面体骨架核酸在骨科中的潜在应用

Potential Applications of the Tetrahedral Framework Nucleic Acid in Orthopaedics.

靶向 B7-H3-CAR-T 细胞中的 Regnase-1 重编程肿瘤微环境并增强骨肉瘤抗肿瘤疗效

Targeting Regnase-1 in B7-H3-CAR T cells reprograms the tumor microenvironment and enhances antitumor efficacy for osteosarcoma.

骨肉瘤肿瘤免疫微环境重塑与病理性骨折风险关联的研究进展

Advances in the association between tumor immune microenvironment remodeling in osteosarcoma and the risk of pathological fractures.

骨肿瘤的新兴治疗：来自 ESMO 年会的经验教训

Emerging Treatments in Bone Tumors: Lessons Learned from the ESMO Annual Meeting.

骨肉瘤的基因免疫治疗：从溶瘤载体到工程化免疫细胞

Gene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells.